{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:45:28Z","timestamp":1791301528777,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>All-cause mortality risk and causes of death in bronchiectasis patients have not been fully investigated. The aim of this study was to compare the mortality risk and causes of death between individuals with bronchiectasis and those without bronchiectasis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Patients with or without bronchiectasis determined based on chest computed tomography (CT) at one centre between 2005 and 2016 were enrolled. Among the patients without bronchiectasis, a control group was selected after applying additional exclusion criteria. We compared the mortality risk and causes of death between the bronchiectasis and control groups without lung disease. Subgroup analyses were also performed according to identification of <jats:italic>Pseudomonas<\/jats:italic> or non-tuberculous mycobacteria, airflow limitation, and smoking status.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Of the total 217,702 patients who underwent chest CT, 18,134 bronchiectasis patients and 90,313 non-bronchiectasis patients were included. The all-cause mortality rate in the bronchiectasis group was 1608.8 per 100,000 person-years (95% confidence interval (CI), 1531.5\u20131690.0), which was higher than that in the control group (133.5 per 100,000 person-years; 95% CI, 124.1\u2013143.8; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The bronchiectasis group had higher all-cause (adjusted hazard ratio (aHR), 1.26; 95% CI, 1.09\u20131.47), respiratory (aHR, 3.49; 95% CI, 2.21\u20135.51), and lung cancer-related (aHR, 3.48; 95% CI, 2.33\u20135.22) mortality risks than the control group. In subgroup analysis, patients with airflow limitation and ever smokers showed higher all-cause mortality risk among bronchiectasis patients. Therefore, we observed significant interrelation between bronchiectasis and smoking, concerning the risks of all-cause mortality (<jats:italic>P<\/jats:italic> for multiplicative interaction, 0.030, RERI, 0.432; 95% CI, 0.097\u20130.769) and lung cancer-related mortality (RERI, 8.68; 95% CI, 1.631\u201315.736).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Individuals with bronchiectasis had a higher risk of all-cause, respiratory, and lung cancer-related mortality compared to control group. The risk of all-cause mortality was more prominent in those with airflow limitation and in ever smokers.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12931-019-1243-3","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T05:00:01Z","timestamp":1576472401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Mortality risk and causes of death in patients with non-cystic fibrosis bronchiectasis"],"prefix":"10.1186","volume":"20","author":[{"given":"Sooim","family":"Sin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo Young","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeyoung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Mi","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Sik","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Gyu","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Whan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Koo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9960-1524","authenticated-orcid":false,"given":"Chang-Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,3]]},"reference":[{"issue":"6","key":"1243_CR1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","volume":"188","author":"PJ McShane","year":"2013","unstructured":"McShane PJ, Naureckas ET, Tino G, Strek ME. Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2013;188(6):647\u201356.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1243_CR2","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/resp.13005","volume":"22","author":"V Venning","year":"2017","unstructured":"Venning V, Bartlett J, Jayaram L. Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: clinical, physiological and sputum characteristics. Respirology. 2017;22(5):922\u20137.","journal-title":"Respirology"},{"issue":"4","key":"1243_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.cpm.0000171422.98696.ed","volume":"12","author":"D Weycker","year":"2005","unstructured":"Weycker D, Edelsberg J, Oster G, Tino G. Prevalence and economic burden of bronchiectasis. Clin Pulm Med. 2005;12(4):205\u20139.","journal-title":"Clin Pulm Med"},{"issue":"2","key":"1243_CR4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1378\/chest.11-2209","volume":"142","author":"AE Seitz","year":"2012","unstructured":"Seitz AE, Olivier KN, Adjemian J, Holland SM, Prevots DR. Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007. Chest. 2012;142(2):432\u20139.","journal-title":"Chest"},{"issue":"8","key":"1243_CR5","doi-asserted-by":"publisher","first-page":"e71109","DOI":"10.1371\/journal.pone.0071109","volume":"8","author":"FC Ringshausen","year":"2013","unstructured":"Ringshausen FC, de Roux A, Pletz MW, Hamalainen N, Welte T, Rademacher J. Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends. PLoS One. 2013;8(8):e71109.","journal-title":"PLoS One"},{"issue":"3","key":"1243_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40258-013-0027-z","volume":"11","author":"VN Joish","year":"2013","unstructured":"Joish VN, Spilsbury-Cantalupo M, Operschall E, Luong B, Boklage S. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective. Appl Health Econ Health Policy. 2013;11(3):299\u2013304.","journal-title":"Appl Health Econ Health Policy"},{"issue":"6","key":"1243_CR7","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1111\/j.1445-5994.2011.02444.x","volume":"42","author":"ME Roberts","year":"2012","unstructured":"Roberts ME, Lowndes L, Milne DG, Wong CA. Socioeconomic deprivation, readmissions, mortality and acute exacerbations of bronchiectasis. Intern Med J. 2012;42(6):e129\u201336.","journal-title":"Intern Med J"},{"key":"1243_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41533-017-0019-9","volume":"27","author":"JD Chalmers","year":"2017","unstructured":"Chalmers JD, Sethi S. Raising awareness of bronchiectasis in primary care: overview of diagnosis and management strategies in adults. NPJ Prim Care Respir Med. 2017;27:18.","journal-title":"NPJ Prim Care Respir Med"},{"issue":"2","key":"1243_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.rmed.2013.12.015","volume":"108","author":"PC Goeminne","year":"2014","unstructured":"Goeminne PC, Nawrot TS, Ruttens D, Seys S, Dupont LJ. Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis. Respir Med. 2014;108(2):287\u201396.","journal-title":"Respir Med"},{"issue":"1","key":"1243_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1465-9921-13-21","volume":"13","author":"PC Goeminne","year":"2012","unstructured":"Goeminne PC, Scheers H, Decraene A, Seys S, Dupont LJ. Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients. Respir Res. 2012;13(1):21.","journal-title":"Respir Res"},{"issue":"5","key":"1243_CR11","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","volume":"189","author":"JD Chalmers","year":"2014","unstructured":"Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189(5):576\u201385.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1243_CR12","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1183\/09031936.00003709","volume":"34","author":"MR Loebinger","year":"2009","unstructured":"Loebinger MR, Wells AU, Hansell DM, Chinyanganya N, Devaraj A, Meister M, et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J. 2009;34(4):843\u20139.","journal-title":"Eur Respir J"},{"issue":"7","key":"1243_CR13","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.rmed.2007.02.002","volume":"101","author":"ZP Onen","year":"2007","unstructured":"Onen ZP, Gulbay BE, Sen E, Yildiz OA, Saryal S, Acican T, et al. Analysis of the factors related to mortality in patients with bronchiectasis. Respir Med. 2007;101(7):1390\u20137.","journal-title":"Respir Med"},{"issue":"9","key":"1243_CR14","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/thx.36.9.659","volume":"36","author":"DA Ellis","year":"1981","unstructured":"Ellis DA, Thornley PE, Wightman AJ, Walker M, Chalmers J, Crofton JW. Present outlook in bronchiectasis: clinical and social study and review of factors influencing prognosis. Thorax. 1981;36(9):659\u201364.","journal-title":"Thorax"},{"issue":"6","key":"1243_CR15","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.rmed.2014.07.021","volume":"109","author":"MJ McDonnell","year":"2015","unstructured":"McDonnell MJ, Jary HR, Perry A, MacFarlane JG, Hester KL, Small T, et al. Non cystic fibrosis bronchiectasis: a longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance. Respir Med. 2015;109(6):716\u201326.","journal-title":"Respir Med"},{"key":"1243_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.rmed.2016.10.014","volume":"121","author":"M Monteagudo","year":"2016","unstructured":"Monteagudo M, Rodriguez-Blanco T, Barrecheguren M, Simonet P, Miravitlles M. Prevalence and incidence of bronchiectasis in Catalonia, Spain: a population-based study. Respir Med. 2016;121:26\u201331.","journal-title":"Respir Med"},{"key":"1243_CR17","first-page":"6","volume":"147","author":"PJ Cole","year":"1986","unstructured":"Cole PJ. Inflammation: a two-edged sword--the model of bronchiectasis. Eur J Respir Dis Suppl. 1986;147:6\u201315.","journal-title":"Eur J Respir Dis Suppl"},{"issue":"12","key":"1243_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm5120115","volume":"5","author":"JK Khoo","year":"2016","unstructured":"Khoo JK, Venning V, Wong C, Jayaram L. Bronchiectasis in the last five years: new developments. J Clin Med. 2016;5(12):e115.","journal-title":"J Clin Med"},{"key":"1243_CR19","doi-asserted-by":"crossref","unstructured":"Barton J, Scott L, Maguire G. Bronchiectasis in the Kimberley region of Western Australia. Aust J Rural Health. 2018.","DOI":"10.1111\/ajr.12411"},{"issue":"12","key":"1243_CR20","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1183\/09031936.97.10122784","volume":"10","author":"T Keistinen","year":"1997","unstructured":"Keistinen T, Saynajakangas O, Tuuponen T, Kivela SL. Bronchiectasis: an orphan disease with a poorly-understood prognosis. Eur Respir J. 1997;10(12):2784\u20137.","journal-title":"Eur Respir J"},{"issue":"1","key":"1243_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12890-016-0311-4","volume":"16","author":"YW Kim","year":"2016","unstructured":"Kim YW, Lee CH, Jin KN, Lee JK, Heo EY, Park SS, et al. The regional association between bronchiectasis and lung cancer in chest CT. BMC Pulm Med. 2016;16(1):151.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"1243_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/qjmed\/hcu237","volume":"109","author":"WS Chung","year":"2016","unstructured":"Chung WS, Lin CL, Hsu WH, Kao CH. Increased risk of lung cancer among patients with bronchiectasis: a nationwide cohort study. QJM. 2016;109(1):17\u201325.","journal-title":"QJM"},{"issue":"6","key":"1243_CR23","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883\u201399.","journal-title":"Cell"},{"issue":"3","key":"1243_CR24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.critrevonc.2013.06.011","volume":"88","author":"AG Pallis","year":"2013","unstructured":"Pallis AG, Syrigos KN. Lung cancer in never smokers: disease characteristics and risk factors. Crit Rev Oncol Hematol. 2013;88(3):494\u2013503.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8","key":"1243_CR25","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/JTO.0b013e31818020eb","volume":"3","author":"DR Youlden","year":"2008","unstructured":"Youlden DR, Cramb SM, Baade PD. The international epidemiology of lung Cancer: geographical distribution and secular trends. J Thorac Oncol. 2008;3(8):819\u201331.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"1243_CR26","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1378\/chest.125.5.1815","volume":"125","author":"M Dupont","year":"2004","unstructured":"Dupont M, Gacouin A, Lena H, Lavoue S, Brinchault G, Delaval P, et al. Survival of patients with bronchiectasis after the first ICU stay for respiratory failure. Chest. 2004;125(5):1815\u201320.","journal-title":"Chest"},{"key":"1243_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/COPD.S121943","volume":"12","author":"MA Martinez-Garcia","year":"2017","unstructured":"Martinez-Garcia MA, Athanazio RA, Giron R, Maiz-Carro L, de la Rosa D, Olveira C, et al. Predicting high risk of exacerbations in bronchiectasis: the E-FACED score. Int J Chron Obstruct Pulmon Dis. 2017;12:275\u201384.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"11","key":"1243_CR28","first-page":"1602","volume":"12","author":"S Finch","year":"2015","unstructured":"Finch S, McDonnell MJ, Abo-Leyah H, Aliberti S, Chalmers JD. A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis. Ann Am Thorac Soc. 2015;12(11):1602\u201311.","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"1243_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ppul.10127","volume":"34","author":"J Emerson","year":"2002","unstructured":"Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002;34(2):91\u2013100.","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"1243_CR30","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S0022-3476(05)82653-8","volume":"116","author":"E Kerem","year":"1990","unstructured":"Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr. 1990;116(5):714\u20139.","journal-title":"J Pediatr"},{"issue":"1","key":"1243_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/ppul.1950190103","volume":"19","author":"A Pamukcu","year":"1995","unstructured":"Pamukcu A, Bush A, Buchdahl R. Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pediatr Pulmonol. 1995;19(1):10\u20135.","journal-title":"Pediatr Pulmonol"},{"issue":"11","key":"1243_CR32","doi-asserted-by":"publisher","first-page":"e1000","DOI":"10.1016\/j.ijid.2013.03.018","volume":"17","author":"M Mirsaeidi","year":"2013","unstructured":"Mirsaeidi M, Hadid W, Ericsoussi B, Rodgers D, Sadikot RT. Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis. Int J Infect Dis. 2013;17(11):e1000\u2013e4.","journal-title":"Int J Infect Dis"},{"issue":"11","key":"1243_CR33","first-page":"1913","volume":"17","author":"P Faverio","year":"2016","unstructured":"Faverio P, Stainer A, Bonaiti G, Zucchetti S, Simonetta E, Lapadula G, et al. Characterizing non-Tuberculous mycobacteria infection in bronchiectasis. Int J Mol Cell Med. 2016;17(11):1913.","journal-title":"Int J Mol Cell Med"},{"issue":"9","key":"1243_CR34","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/oxfordjournals.aje.a116396","volume":"135","author":"S Wacholder","year":"1992","unstructured":"Wacholder S, McLaughlin JK, Silverman DT, Mandel JS. Selection of controls in case-control studies. I Principles Am J Epidemiol. 1992;135(9):1019\u201328.","journal-title":"I Principles Am J Epidemiol"},{"issue":"9468","key":"1243_CR35","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(05)66379-9","volume":"365","author":"DA Grimes","year":"2005","unstructured":"Grimes DA, Schulz KF. Compared to what? Finding controls for case-control studies. Lancet. 2005;365(9468):1429\u201333.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"1243_CR36","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thx.2010.136119","volume":"65","author":"MC Pasteur","year":"2010","unstructured":"Pasteur MC, Bilton D, Hill AT. British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010;65(Suppl 1):i1\u201358.","journal-title":"Thorax"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1243-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-019-1243-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1243-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T19:39:35Z","timestamp":1606851575000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-019-1243-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1243"],"URL":"https:\/\/doi.org\/10.1186\/s12931-019-1243-3","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"11 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of the Seoul National University Hospital (IRB No. H-1607-037-774) and conformed to the tenets of the Declaration of Helsinki. Informed consent was waived due to its retrospective nature.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"271"}}